Systemic Lupus Erythematosus
📧 Sign up to get email alerts when something new happens for Systemic Lupus Erythematosus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-08-29Clinical Trial Update: An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease [NA]
This clinical trial update reports a study of YTS109 cell injection for recurrent or refractory autoimmune diseases that is currently recrui…
-
CLINICAL_TRIALS trial_result · 2024-08-22Clinical Trial Update: Exercise and Arterial Stiffness in Systemic Lupus Erythematosus [NA]
This clinical trial examining the effect of exercise on arterial stiffness in systemic lupus erythematosus has completed and posted results.
-
CLINICAL_TRIALS research · 2024-08-22Clinical Trial Update: JWCAR201 for the Treatment of Hematology Malignancy and Autoimmune Diseases [Phase 1]
This clinical trial update outlines the Phase 1 study JWCAR201 for hematology malignancies and autoimmune diseases, which is currently not r…
-
CLINICAL_TRIALS trial_result · 2024-08-20Clinical Trial Update: Effects of Nigella Sativa on T Cells and Cytokine Profile in Pediatric SLE Patients [NA]
A completed clinical trial assessing the immunomodulatory effects of Nigella Sativa on T cells and cytokine profiles in pediatric systemic l…
-
CLINICAL_TRIALS research · 2024-08-16Clinical Trial Update: Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Systemic Lupus Erythematosus [Phase 2]
A Phase 2 clinical trial is evaluating the efficacy and safety of Orelabrutinib in adults with systemic lupus erythematosus; the study is cu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA label_change · 2024-08-13FDA Approved: MYCOPHENOLIC ACID — Supplemental Application (Biocon Pharma Inc.)
FDA approved a supplemental application for Mycophenolic acid filed by Biocon Pharma Inc., updating the labeling for the product.
-
CLINICAL_TRIALS research · 2024-08-13Clinical Trial Update: Follow-up of the Systemic Lupus Erythematosus Cohort as Part of the Multidisciplinary Consultation at Brest CHRU
This clinical trial entry describes a follow-up cohort study on systemic lupus erythematosus at Brest CHRU, currently recruiting as part of …
-
CLINICAL_TRIALS trial_result · 2024-08-12Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacokinetic of TQB3702 Tablets in Healthy Adult Subjects [Phase 1]
This Phase 1 trial evaluates the safety and pharmacokinetics of TQB3702 tablets in healthy adult subjects. The listed condition associated w…
-
CLINICAL_TRIALS research · 2024-08-09Clinical Trial Update: Integration of Remote Monitoring in the Management of Chronic Immunosuppressive Therapy [NA]
Clinical trial update on integrating remote monitoring into chronic immunosuppressive therapy for rheumatoid arthritis, psoriatic arthritis,…
-
FDA label_change · 2024-08-07FDA Approved: SAPHNELO — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for SAPHNELO (ANIFROLUMAB-FNIA) from AstraZeneca Pharmaceuticals LP. The action pertains to a labeli…
-
CLINICAL_TRIALS trial_result · 2024-08-06Clinical Trial Update: CCCR Lupus Patient Navigator Program [NA]
The CCCR Lupus Patient Navigator Program trial for systemic lupus erythematosus has completed and posted results in August 2024.
-
CLINICAL_TRIALS research · 2024-08-06Clinical Trial Update: Osteoporosis and Fragility Fractures Among SLE Patients. (FRAIL Trial)
The FRAIL Trial is studying osteoporosis and fragility fractures in patients with systemic lupus erythematosus and is currently active but n…
-
CLINICAL_TRIALS research · 2024-08-05Clinical Trial Update: Glycosylation Analysis of Lupus Anti-DNA Antibodies (GALA)
The GALA clinical trial is currently recruiting to study glycosylation analysis of lupus anti-DNA antibodies.
-
CLINICAL_TRIALS other · 2024-08-02Clinical Trial Update: A Study of IMC-002 for the Treatment of Active Systemic Lupus Erythematosus [Phase 1, Phase 2]
Phase 1/2 trial of IMC-002 for active systemic lupus erythematosus has not yet begun recruiting.
-
CLINICAL_TRIALS research · 2024-07-31Clinical Trial Update: Validation of Patient E-tool to Measure Systemic Lupus Activity
The clinical trial update reports completion of a study validating an electronic patient-reported tool to measure systemic lupus erythematos…
-
CLINICAL_TRIALS trial_result · 2024-07-30Clinical Trial Update: Open-label Study of Tofacitinib for Moderate to Severe Skin Involvement in Young Adults With Lupus [Phase 1, Phase 2]
An open-label Phase 1/2 trial evaluating the JAK inhibitor tofacitinib for cutaneous lupus erythematosus and systemic lupus erythematosus in…
-
CLINICAL_TRIALS trial_result · 2024-07-23Clinical Trial Update: Study of VIB7734 for the Treatment of Moderate to Severely Active SLE [Phase 2]
Phase 2 study of VIB7734 in moderate-to-severe systemic lupus erythematosus has completed, with results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-07-16Clinical Trial Update: Multicenter Trial Evaluating the Immunogenicity of HPV Vaccination in Girls on Immunosuppressive Therapy. [Phase 2]
A multicenter Phase 2 trial evaluating the immunogenicity of HPV vaccination in girls on immunosuppressive therapy, including those with sys…
-
CLINICAL_TRIALS research · 2024-07-15Clinical Trial Update: Individual Patient Exposure and Response in Pediatric Lupus [NA]
A completed clinical trial update examining individual patient exposure and response in pediatric Systemic Lupus Erythematosus.
-
CLINICAL_TRIALS research · 2024-07-09Clinical Trial Update: Effectiveness of Mycophenolate Mofetil Combined With Tacrolimus for Steroid Tapering in Systemic Lupus Erythematosus [Phase 4]
A Phase 4 clinical trial is evaluating whether adding tacrolimus to mycophenolate mofetil helps taper steroids in systemic lupus erythematos…
-
CLINICAL_TRIALS research · 2024-07-09Clinical Trial Update: A Study of Clinical Characteristics ,Risk Factors and Outcome of Lupus Nephritis Among Children With Systemic Lupus Erthromatousus in Sohag Univeristy Hospital
A pediatric study at Sohag University Hospital investigates clinical characteristics, risk factors, and outcomes of lupus nephritis in child…
-
CLINICAL_TRIALS research · 2024-07-03Clinical Trial Update: Efficacy and Safety of Telitacicept for Prevention of Flares in SLE Patients [NA]
Telitacicept is being studied in a clinical trial to prevent flares in systemic lupus erythematosus, with recruitment ongoing at RenJi Hospi…
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: Neuromuscular Ultrasonography Assessment of Optic Nerve in Systemic Lupus Eryhematosus
Completed clinical study evaluating neuromuscular ultrasonography of the optic nerve in patients with optic neuropathy associated with syste…
-
CLINICAL_TRIALS trial_result · 2024-06-28Clinical Trial Update: Efficacy and Safety of Efavaleukin Alfa in Subjects With Active Systemic Lupus Erythematosus [Phase 2]
A Phase 2 trial evaluating Efavaleukin Alfa for active systemic lupus erythematosus was terminated, with efficacy and safety results posted …
-
CLINICAL_TRIALS trial_result · 2024-06-27Clinical Trial Update: LUPUS Brain: tACS to Target the Neurophysiology of Depression, Cognitive Deficits, and Pain in Patients With SLE [NA]
A terminated UNC-Chapel Hill study assessed transcranial alternating current stimulation to address depression, cognitive deficits, and pain…